<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Fanconi_syndrome</id>
	<title>Fanconi syndrome - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Fanconi_syndrome"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Fanconi_syndrome&amp;action=history"/>
	<updated>2026-04-19T14:22:45Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Fanconi_syndrome&amp;diff=389425&amp;oldid=prev</id>
		<title>Danbot: Strip excess bold</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Fanconi_syndrome&amp;diff=389425&amp;oldid=prev"/>
		<updated>2026-03-22T09:36:50Z</updated>

		<summary type="html">&lt;p&gt;Strip excess bold&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 09:36, 22 March 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l47&quot;&gt;Line 47:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 47:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Acute/ED presentation===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Acute/ED presentation===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Hypokalemia]] — may be '''severe and life-threatening'''; case reports of [[Cardiac arrest|cardiac arrest]] from Fanconi-related hypokalemia&amp;lt;ref name=&amp;quot;Cardiac&amp;quot;&amp;gt;A 57-Year-Old Female Presenting With Cardiopulmonary Arrest Secondary to Severe Hypokalemia From a Fanconi-Like Syndrome. ''Cureus''. 2024;16(3):e55705. doi:10.7759/cureus.55705&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Hypokalemia]] — may be '''severe and life-threatening'''; case reports of [[Cardiac arrest|cardiac arrest]] from Fanconi-related hypokalemia&amp;lt;ref name=&amp;quot;Cardiac&amp;quot;&amp;gt;A 57-Year-Old Female Presenting With Cardiopulmonary Arrest Secondary to Severe Hypokalemia From a Fanconi-Like Syndrome. ''Cureus''. 2024;16(3):e55705. doi:10.7759/cureus.55705&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Metabolic acidosis]] — non-anion gap (hyperchloremic) from &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;proximal (type 2) [[Renal tubular acidosis|RTA]]&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(bicarbonate wasting)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Metabolic acidosis]] — non-anion gap (hyperchloremic) from proximal (type 2) [[Renal tubular acidosis|RTA]] (bicarbonate wasting)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Polyuria, polydipsia (from impaired water/sodium reabsorption)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Polyuria, polydipsia (from impaired water/sodium reabsorption)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Dehydration, volume depletion&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Dehydration, volume depletion&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l126&quot;&gt;Line 126:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 126:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Diagnosis===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Diagnosis===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Clinical diagnosis based on the &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;constellation&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;of: glycosuria with normoglycemia + generalized aminoaciduria + phosphaturia + bicarbonaturia + hypokalemia&amp;lt;ref name=&amp;quot;MerckManual&amp;quot;&amp;gt;Fanconi Syndrome. ''Merck Manual Professional Edition''. 2024.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Clinical diagnosis based on the constellation of: glycosuria with normoglycemia + generalized aminoaciduria + phosphaturia + bicarbonaturia + hypokalemia&amp;lt;ref name=&amp;quot;MerckManual&amp;quot;&amp;gt;Fanconi Syndrome. ''Merck Manual Professional Edition''. 2024.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*No single test is diagnostic; the &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;pattern&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;of proximal tubular losses is key&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*No single test is diagnostic; the pattern of proximal tubular losses is key&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Once Fanconi syndrome is identified, the underlying cause must be sought&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Once Fanconi syndrome is identified, the underlying cause must be sought&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l133&quot;&gt;Line 133:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 133:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Emergency management (acute presentations)===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Emergency management (acute presentations)===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Hypokalemia:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Hypokalemia:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Aggressive IV and PO potassium repletion; may be &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;profoundly refractory&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;due to ongoing renal losses&amp;lt;ref name=&amp;quot;Cardiac&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Aggressive IV and PO potassium repletion; may be profoundly refractory due to ongoing renal losses&amp;lt;ref name=&amp;quot;Cardiac&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Continuous cardiac monitoring if K⁺ &amp;lt;3.0 mEq/L or symptomatic&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Continuous cardiac monitoring if K⁺ &amp;lt;3.0 mEq/L or symptomatic&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Target serum K⁺ &amp;gt;4.0 mEq/L&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Target serum K⁺ &amp;gt;4.0 mEq/L&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Consider &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;amiloride&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;or &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;spironolactone&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;to reduce renal potassium wasting&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Consider amiloride or spironolactone to reduce renal potassium wasting&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Metabolic acidosis:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Metabolic acidosis:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Oral or IV &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;sodium bicarbonate&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;or &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;sodium citrate/potassium citrate&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(Bicitra, Polycitra)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Oral or IV sodium bicarbonate or sodium citrate/potassium citrate (Bicitra, Polycitra)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Large doses may be required (10-15 mEq/kg/day in children) because bicarbonate is lost in the urine&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Large doses may be required (10-15 mEq/kg/day in children) because bicarbonate is lost in the urine&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Caution: bicarbonate repletion may worsen hypokalemia (drives K⁺ intracellularly and increases distal delivery); replete potassium FIRST or concurrently&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Caution: bicarbonate repletion may worsen hypokalemia (drives K⁺ intracellularly and increases distal delivery); replete potassium FIRST or concurrently&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l152&quot;&gt;Line 152:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 152:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Valproic acid: consider alternative antiepileptic&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Valproic acid: consider alternative antiepileptic&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Expired tetracyclines: discard&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Expired tetracyclines: discard&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Recovery after drug withdrawal may take &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;weeks to months&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&amp;lt;ref name=&amp;quot;Medscape&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Recovery after drug withdrawal may take weeks to months&amp;lt;ref name=&amp;quot;Medscape&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Heavy metal poisoning: chelation therapy as appropriate (see [[Lead poisoning]])&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Heavy metal poisoning: chelation therapy as appropriate (see [[Lead poisoning]])&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Multiple myeloma/paraproteinemia: hematology/oncology referral for treatment of underlying disease&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Multiple myeloma/paraproteinemia: hematology/oncology referral for treatment of underlying disease&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Cystinosis: &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;cysteamine&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(Cystagon) — reduces intracellular cystine accumulation; early initiation improves renal outcomes&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Cystinosis: cysteamine (Cystagon) — reduces intracellular cystine accumulation; early initiation improves renal outcomes&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Long-term supplementation===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Long-term supplementation===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Fanconi_syndrome&amp;diff=386210&amp;oldid=prev</id>
		<title>Danbot: Moved intro paragraph into Background as bullets; removed excessive bold from bullet lead-ins; added Renal tubular disorders, Hypokalemia, and Acid-base disorders DDX templates; bold retained for critical items only</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Fanconi_syndrome&amp;diff=386210&amp;oldid=prev"/>
		<updated>2026-03-19T14:27:32Z</updated>

		<summary type="html">&lt;p&gt;Moved intro paragraph into Background as bullets; removed excessive bold from bullet lead-ins; added Renal tubular disorders, Hypokalemia, and Acid-base disorders DDX templates; bold retained for critical items only&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=Fanconi_syndrome&amp;amp;diff=386210&amp;amp;oldid=386152&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Fanconi_syndrome&amp;diff=386152&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;Fanconi syndrome is a generalized dysfunction of the '''proximal renal tubule''' resulting in impaired reabsorption of glucose, amino acids, phosphate, bicarbonate, uric acid, potassium, sodium, and low-molecular-weight proteins. It produces a '''type 2 (proximal) renal tubular acidosis''' and may cause life-threatening hypokalemia, metabolic acidosis, dehydration, and bone disease.&lt;ref name=&quot;StatPearls&quot;&gt;F...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Fanconi_syndrome&amp;diff=386152&amp;oldid=prev"/>
		<updated>2026-03-17T23:43:39Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Fanconi syndrome is a generalized dysfunction of the &amp;#039;&amp;#039;&amp;#039;proximal renal tubule&amp;#039;&amp;#039;&amp;#039; resulting in impaired reabsorption of glucose, amino acids, phosphate, bicarbonate, uric acid, potassium, sodium, and low-molecular-weight proteins. It produces a &amp;#039;&amp;#039;&amp;#039;type 2 (proximal) &lt;a href=&quot;/wiki/Renal_tubular_acidosis&quot; title=&quot;Renal tubular acidosis&quot;&gt;renal tubular acidosis&lt;/a&gt;&amp;#039;&amp;#039;&amp;#039; and may cause life-threatening &lt;a href=&quot;/wiki/Hypokalemia&quot; title=&quot;Hypokalemia&quot;&gt;hypokalemia&lt;/a&gt;, &lt;a href=&quot;/wiki/Metabolic_acidosis&quot; title=&quot;Metabolic acidosis&quot;&gt;metabolic acidosis&lt;/a&gt;, dehydration, and bone disease.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;F...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Fanconi syndrome is a generalized dysfunction of the '''proximal renal tubule''' resulting in impaired reabsorption of glucose, amino acids, phosphate, bicarbonate, uric acid, potassium, sodium, and low-molecular-weight proteins. It produces a '''type 2 (proximal) [[Renal tubular acidosis|renal tubular acidosis]]''' and may cause life-threatening [[Hypokalemia|hypokalemia]], [[Metabolic acidosis|metabolic acidosis]], dehydration, and bone disease.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Fanconi Syndrome. ''StatPearls''. 2025. PMID: 30521243&amp;lt;/ref&amp;gt; It is '''not''' the same as [[Fanconi anemia]], which is a separate inherited bone marrow failure syndrome.&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
*The proximal convoluted tubule (PCT) normally reabsorbs ~65% of filtered sodium, water, bicarbonate, glucose, amino acids, phosphate, and uric acid&lt;br /&gt;
*In Fanconi syndrome, '''global PCT dysfunction''' causes urinary wasting of all these solutes simultaneously&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*Pathophysiology centers on '''mitochondrial dysfunction → ATP depletion → failure of Na⁺/K⁺-ATPase''' and energy-dependent transport systems&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*Can be '''inherited''' or '''acquired'''; acquired forms are more relevant to the emergency physician&lt;br /&gt;
&lt;br /&gt;
===Inherited causes===&lt;br /&gt;
*'''[[Cystinosis]]''' — most common inherited cause (presents in infancy, 6-18 months)&lt;br /&gt;
*[[Wilson disease]]&lt;br /&gt;
*Hereditary fructose intolerance&lt;br /&gt;
*Galactosemia&lt;br /&gt;
*Glycogen storage diseases&lt;br /&gt;
*Lowe syndrome (oculocerebrorenal syndrome)&lt;br /&gt;
*Dent disease&lt;br /&gt;
*Fanconi-Bickel syndrome&lt;br /&gt;
*Tyrosinemia type 1&lt;br /&gt;
*Mitochondrial cytopathies&lt;br /&gt;
&lt;br /&gt;
===Acquired causes (most EM-relevant)===&lt;br /&gt;
*'''Medications''' (most common acquired cause):&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;Medscape&amp;quot;&amp;gt;Fanconi Syndrome. ''Medscape''. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**'''Tenofovir''' (TDF; especially in HIV patients with pre-existing renal impairment) — most commonly encountered drug cause today&lt;br /&gt;
**'''Ifosfamide''' — particularly in children after cumulative doses&lt;br /&gt;
**'''Cisplatin, carboplatin'''&lt;br /&gt;
**'''Valproic acid''' — especially with polytherapy and prolonged use&lt;br /&gt;
**'''Expired tetracyclines''' (degradation products are directly nephrotoxic)&lt;br /&gt;
**Adefovir, cidofovir, didanosine&lt;br /&gt;
**Aminoglycosides (gentamicin)&lt;br /&gt;
**Lenalidomide, streptozocin&lt;br /&gt;
*'''Heavy metals:'''&lt;br /&gt;
**[[Lead poisoning]] (most common heavy metal cause in children)&lt;br /&gt;
**Cadmium, mercury, platinum, uranium&lt;br /&gt;
*'''Paraproteinemia:'''&lt;br /&gt;
**[[Multiple myeloma]] (light chain proximal tubulopathy)&lt;br /&gt;
**AL amyloidosis&lt;br /&gt;
*'''Other:'''&lt;br /&gt;
**Renal transplant&lt;br /&gt;
**Toluene exposure (glue sniffing)&lt;br /&gt;
**Aristolochic acid (herbal medicines)&lt;br /&gt;
**Paraquat poisoning&lt;br /&gt;
&lt;br /&gt;
==Clinical features==&lt;br /&gt;
*Presentation varies widely depending on the underlying cause, severity, and chronicity&lt;br /&gt;
*May range from an incidental laboratory finding to life-threatening electrolyte emergency&lt;br /&gt;
&lt;br /&gt;
===Acute/ED presentation===&lt;br /&gt;
*'''[[Hypokalemia]]''' — may be '''severe and life-threatening'''; case reports of [[Cardiac arrest|cardiac arrest]] from Fanconi-related hypokalemia&amp;lt;ref name=&amp;quot;Cardiac&amp;quot;&amp;gt;A 57-Year-Old Female Presenting With Cardiopulmonary Arrest Secondary to Severe Hypokalemia From a Fanconi-Like Syndrome. ''Cureus''. 2024;16(3):e55705. doi:10.7759/cureus.55705&amp;lt;/ref&amp;gt;&lt;br /&gt;
*'''[[Metabolic acidosis]]''' — non-anion gap (hyperchloremic) from '''proximal (type 2) [[Renal tubular acidosis|RTA]]''' (bicarbonate wasting)&lt;br /&gt;
*'''Polyuria, polydipsia''' (from impaired water/sodium reabsorption)&lt;br /&gt;
*'''Dehydration''', volume depletion&lt;br /&gt;
*'''Muscle weakness''' (from hypokalemia and hypophosphatemia)&lt;br /&gt;
*Nausea, vomiting&lt;br /&gt;
*Fatigue, malaise&lt;br /&gt;
&lt;br /&gt;
===Chronic/subacute presentation===&lt;br /&gt;
*'''Children:'''&lt;br /&gt;
**Failure to thrive, growth retardation&lt;br /&gt;
**'''Rickets''' (hypophosphatemic; from phosphate wasting + impaired 1,25-dihydroxyvitamin D synthesis in PCT)&lt;br /&gt;
**Bone pain, pathologic fractures&lt;br /&gt;
**Polyuria, polydipsia&lt;br /&gt;
*'''Adults:'''&lt;br /&gt;
**'''Osteomalacia''' (bone pain, pathologic fractures, proximal muscle weakness)&lt;br /&gt;
**Chronic fatigue, muscle weakness&lt;br /&gt;
**Kidney stones (hypercalciuria in some forms)&lt;br /&gt;
**Progressive chronic kidney disease&lt;br /&gt;
*'''Cystinosis-specific:''' corneal cystine crystals, hepatomegaly, hypothyroidism, retinal depigmentation, growth failure&lt;br /&gt;
&lt;br /&gt;
===Key laboratory pattern (&amp;quot;the Fanconi fingerprint&amp;quot;)===&lt;br /&gt;
*'''Glycosuria with NORMAL serum glucose''' (not diabetes — inappropriately low renal glucose threshold)&lt;br /&gt;
*'''Generalized aminoaciduria'''&lt;br /&gt;
*'''Phosphaturia''' with hypophosphatemia&lt;br /&gt;
*'''Bicarbonaturia''' with non-anion gap metabolic acidosis (proximal RTA)&lt;br /&gt;
*'''Hypokalemia''' (renal potassium wasting)&lt;br /&gt;
*'''Hypouricemia''' (uric acid wasting)&lt;br /&gt;
*'''Low-molecular-weight proteinuria''' (β₂-microglobulin, retinol-binding protein)&lt;br /&gt;
&lt;br /&gt;
==Differential diagnosis==&lt;br /&gt;
===Proximal [[Renal tubular acidosis]]===&lt;br /&gt;
*Isolated proximal RTA (type 2) without full Fanconi features&lt;br /&gt;
*[[Renal tubular acidosis]] (type 1)&lt;br /&gt;
*Type 4 RTA (hypoaldosteronism)&lt;br /&gt;
&lt;br /&gt;
===Other causes of non-anion gap metabolic acidosis===&lt;br /&gt;
*Diarrhea&lt;br /&gt;
*Ureteral diversion&lt;br /&gt;
*Carbonic anhydrase inhibitors (acetazolamide)&lt;br /&gt;
&lt;br /&gt;
===Other causes of unexplained hypokalemia===&lt;br /&gt;
*Diuretic use&lt;br /&gt;
*[[Hyperaldosteronism]]&lt;br /&gt;
*[[Bartter syndrome]], [[Gitelman syndrome]]&lt;br /&gt;
*Vomiting, GI losses&lt;br /&gt;
*Licorice ingestion&lt;br /&gt;
&lt;br /&gt;
===Other causes of glycosuria with normal glucose===&lt;br /&gt;
*Renal glycosuria (isolated SGLT2 mutation)&lt;br /&gt;
*Pregnancy&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
===Workup===&lt;br /&gt;
*'''BMP:''' hypokalemia, hypophosphatemia, low bicarbonate (non-anion gap metabolic acidosis), low uric acid; BUN/creatinine for renal function&lt;br /&gt;
*'''ABG/VBG:''' non-anion gap metabolic acidosis (hyperchloremic); urine pH may be &amp;lt;5.5 (unlike distal RTA) if serum bicarbonate is below the reabsorptive threshold&lt;br /&gt;
*'''Urinalysis:'''&lt;br /&gt;
**'''Glucosuria''' (with normal serum glucose — the hallmark clue)&lt;br /&gt;
**Proteinuria (low-molecular-weight)&lt;br /&gt;
*'''Urine electrolytes:''' elevated urine potassium (transtubular potassium gradient &amp;gt;7 suggests renal K⁺ wasting)&lt;br /&gt;
*'''Urine amino acids:''' generalized aminoaciduria (elevated excretion of virtually all amino acids)&lt;br /&gt;
*'''Fractional excretion of phosphate (FePO₄):''' elevated (&amp;gt;5%)&lt;br /&gt;
*'''Fractional excretion of uric acid:''' elevated (&amp;gt;10%)&lt;br /&gt;
*'''Serum phosphate, uric acid, calcium, magnesium, vitamin D (25-OH and 1,25-OH), PTH'''&lt;br /&gt;
*'''Urine β₂-microglobulin''' — marker of proximal tubular injury&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*'''ECG:''' assess for hypokalemia-related changes (U waves, flattened T waves, ST depression, prolonged QT, arrhythmias)&lt;br /&gt;
*'''Additional workup directed at underlying cause:'''&lt;br /&gt;
**Medication review (tenofovir, valproic acid, ifosfamide, expired tetracyclines)&lt;br /&gt;
**Serum and urine protein electrophoresis, free light chains (multiple myeloma)&lt;br /&gt;
**Serum copper, ceruloplasmin ([[Wilson disease]])&lt;br /&gt;
**Lead level&lt;br /&gt;
**White blood cell cystine level (cystinosis)&lt;br /&gt;
**Slit-lamp examination (cystine corneal crystals)&lt;br /&gt;
&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
*Clinical diagnosis based on the '''constellation''' of: glycosuria with normoglycemia + generalized aminoaciduria + phosphaturia + bicarbonaturia + hypokalemia&amp;lt;ref name=&amp;quot;MerckManual&amp;quot;&amp;gt;Fanconi Syndrome. ''Merck Manual Professional Edition''. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*No single test is diagnostic; the '''pattern''' of proximal tubular losses is key&lt;br /&gt;
*Once Fanconi syndrome is identified, the underlying cause must be sought&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
===Emergency management (acute presentations)===&lt;br /&gt;
*'''Hypokalemia:'''&lt;br /&gt;
**Aggressive IV and PO potassium repletion; may be '''profoundly refractory''' due to ongoing renal losses&amp;lt;ref name=&amp;quot;Cardiac&amp;quot;/&amp;gt;&lt;br /&gt;
**Continuous cardiac monitoring if K⁺ &amp;lt;3.0 mEq/L or symptomatic&lt;br /&gt;
**Target serum K⁺ &amp;gt;4.0 mEq/L&lt;br /&gt;
**Consider '''amiloride''' or '''spironolactone''' to reduce renal potassium wasting&lt;br /&gt;
*'''Metabolic acidosis:'''&lt;br /&gt;
**Oral or IV '''sodium bicarbonate''' or '''sodium citrate/potassium citrate''' (Bicitra, Polycitra)&lt;br /&gt;
**Large doses may be required (10-15 mEq/kg/day in children) because bicarbonate is lost in the urine&lt;br /&gt;
**Caution: bicarbonate repletion may worsen hypokalemia (drives K⁺ intracellularly and increases distal delivery); replete potassium FIRST or concurrently&lt;br /&gt;
*'''Dehydration:''' IV fluid resuscitation; may need large volumes due to polyuria&lt;br /&gt;
*'''Hypophosphatemia:'''&lt;br /&gt;
**Oral phosphate supplementation (Neutra-Phos, K-Phos)&lt;br /&gt;
**IV phosphate if severe (&amp;lt;1 mg/dL) or symptomatic&lt;br /&gt;
*'''Hypoglycemia:''' IV dextrose if present (hereditary fructose intolerance may present with hypoglycemia)&lt;br /&gt;
&lt;br /&gt;
===Identify and treat the underlying cause===&lt;br /&gt;
*'''Drug-induced:''' '''discontinue the offending agent''' — this is the most important intervention for acquired Fanconi syndrome&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
**Tenofovir: switch to tenofovir alafenamide (TAF) or alternative antiretroviral&lt;br /&gt;
**Valproic acid: consider alternative antiepileptic&lt;br /&gt;
**Expired tetracyclines: discard&lt;br /&gt;
**Recovery after drug withdrawal may take '''weeks to months'''&amp;lt;ref name=&amp;quot;Medscape&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Heavy metal poisoning:''' chelation therapy as appropriate (see [[Lead poisoning]])&lt;br /&gt;
*'''Multiple myeloma/paraproteinemia:''' hematology/oncology referral for treatment of underlying disease&lt;br /&gt;
*'''Cystinosis:''' '''cysteamine''' (Cystagon) — reduces intracellular cystine accumulation; early initiation improves renal outcomes&lt;br /&gt;
&lt;br /&gt;
===Long-term supplementation===&lt;br /&gt;
*'''Bicarbonate/citrate:''' oral sodium bicarbonate or potassium citrate for chronic metabolic acidosis&lt;br /&gt;
*'''Phosphate:''' oral phosphate supplements&lt;br /&gt;
*'''Vitamin D:''' calcitriol (1,25-dihydroxyvitamin D) — PCT dysfunction impairs conversion of 25-OH to active form&lt;br /&gt;
*'''Potassium:''' oral supplementation; potassium-sparing diuretics if refractory&lt;br /&gt;
*Nephrology follow-up for ongoing management and monitoring of renal function&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*'''Severe hypokalemia (K⁺ &amp;lt;2.5 mEq/L), symptomatic hypokalemia, or cardiac arrhythmias:''' admit to monitored setting; continuous telemetry; serial electrolytes&amp;lt;ref name=&amp;quot;Cardiac&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Severe metabolic acidosis (pH &amp;lt;7.2):''' admit for IV bicarbonate and electrolyte management&lt;br /&gt;
*'''Significant dehydration or hemodynamic instability:''' admit for IV resuscitation&lt;br /&gt;
*'''New diagnosis of Fanconi syndrome:''' may require admission or urgent outpatient workup depending on severity; nephrology consultation&lt;br /&gt;
*'''Stable, known Fanconi syndrome with mild electrolyte abnormalities:''' outpatient management with close nephrology follow-up, medication adjustment, and return precautions for weakness, palpitations, or syncope&lt;br /&gt;
*'''Medication-induced Fanconi:''' ensure offending drug is held and arrange nephrology and primary care follow-up for drug substitution and monitoring of recovery&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Renal tubular acidosis]]&lt;br /&gt;
*[[Hypokalemia]]&lt;br /&gt;
*[[Hypophosphatemia]]&lt;br /&gt;
*[[Metabolic acidosis]]&lt;br /&gt;
*[[Multiple myeloma]]&lt;br /&gt;
*[[Wilson disease]]&lt;br /&gt;
*[[Lead poisoning]]&lt;br /&gt;
*[[Tenofovir]]&lt;br /&gt;
*[[Cystinosis]]&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/books/NBK534872/ StatPearls — Fanconi Syndrome]&lt;br /&gt;
*[https://emedicine.medscape.com/article/981774-overview Medscape — Fanconi Syndrome]&lt;br /&gt;
*[https://www.merckmanuals.com/professional/genitourinary-disorders/renal-transport-abnormalities/fanconi-syndrome Merck Manual — Fanconi Syndrome]&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC10960066/ Cureus — Cardiopulmonary Arrest Secondary to Severe Hypokalemia From Fanconi-Like Syndrome (2024)]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Renal]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>